Baxter International Inc Revenue Growth Rates (BAX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Baxter International Inc   (NYSE: BAX)
 

BAX's Revenue Growth by Quarter and Year

Baxter International Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BAX Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 3,045.00
1st Quarter March 2,701.00
FY 5,746.00

BAXs Annual Revenue
Baxter International Inc 's Revenue in the fiscal year 2025 $ 11,244.00 millions
Baxter International Inc 's Revenue in the fiscal year 2024 $ 10,636.00 millions
Baxter International Inc 's Revenue in the fiscal year 2023 $ 14,813.00 millions
Baxter International Inc 's Revenue in the fiscal year 2022 $ 15,113.00 millions
Baxter International Inc 's Revenue in the fiscal year 2021 $ 12,784.00 millions




BAX Revenue second quarter 2026 Y/Y Growth Comment
Baxter International Inc achieved in the second quarter 2026, above Company average Revenue improvement of 8.36% year on year, to $ 3,045.00 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 151 other companies have achieved higher Revenue growth. While Baxter International Inc ' s Revenue increase of 8.36% ranks overall at the positon no. 3147 in the second quarter 2026.


BAX Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 8.03 % -26.57 % -3.55 %
3rd Quarter September - 5.04 % -27.21 % -1.72 %
2nd Quarter June 8.36 % -26.29 % 2.83 % -1.04 %
1st Quarter March 2.9 % -26.92 % -1.56 % -1.56 %
FY   - -12.54 % -13.21 % -

Financial Statements
Baxter International Inc 's second quarter 2026 Revenue $ 3,045.00 millions BAX's Income Statement
Baxter International Inc 's second quarter 2025 Revenue $ 2,810.00 millions Quarterly BAX's Income Statement


BAX Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 4.9 % 2 % 1.11 %
3rd Quarter September - 0.89 % -29.2 % 0.03 %
2nd Quarter June 12.74 % 7.05 % 6.12 % 1.59 %
1st Quarter March -9.18 % -4.65 % -4.19 % -6.12 %
FY (Year on Year)   - -12.54 % -13.21 % -


Back to BAX Growth rate Comparisons >> Back to BAX Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #152
Healthcare Sector #423
Overall #3147

Revenue Y/Y Growth Statistics
High Average Low
18.38 % 1.45 % -38.44 %
(Sep 30 2022)   (Jun 30 2016)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #152
Healthcare Sector #423
Overall #3147
Revenue Y/Y Growth Statistics
High Average Low
18.38 % 1.45 % -38.44 %
(Sep 30 2022)   (Jun 30 2016)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Baxter International Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
14.52 % 0.59 % -36.12 %
(Dec 31 2013)  


BAX's II. Quarter Q/Q Revenue Comment
Baxter International Inc achieved in the II. Quarter 2026 above company average sequential Revenue rise of 12.74%, to $ 3,045.00 millions, from $2,701.00 millions in the first quarter.
BAX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Baxter International Inc 's Revenue growth quarter on quarter, overall rank is 714.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #119
Overall #714
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #119
Overall #714
Revenue Q/Q Growth Statistics
High Average Low
14.52 % 0.59 % -36.12 %
(Dec 31 2013)  


BAX's II. Quarter Q/Q Revenue Comment
Baxter International Inc achieved in the II. Quarter 2026 above company average sequential Revenue rise of 12.74%, to $ 3,045.00 millions, from $2,701.00 millions in the first quarter.
BAX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Baxter International Inc 's Revenue growth quarter on quarter, overall rank is 714.


Baxter International Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 11,555.00 $ 11,320.00 $ 11,244.00 $ 11,023.00 $ 10,887.00
Y / Y Revenue Growth (TTM) 6.14 % -4.79 % -12.54 % -20.42 % -26.74 %
Year on Year Revenue Growth Overall Ranking # 3472 # 3359 # 3002 # 2704 # 2047
Seqeuential Revenue Change (TTM) 2.08 % 0.68 % 2 % 1.25 % -8.43 %
Seq. Revenue Growth (TTM) Overall Ranking # 3147 # 2169 # 2965 # 2673 # 1912


Cumulative Revenue growth Comment
Baxter International Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 6.14% year on year, to $ 11,555 millions if the fiscal year would have ended in Jun 30 2026.
Baxter International Inc 's trailing twelve months Revenue growth was higher than company's average 1.45% and higher than -4.79% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 2.08 % from $11320 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 1.45%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 2.08 % increase from $11320 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 468 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3359 to 3472.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 152
Healthcare Sector # 469
Overall # 3472

Revenue TTM Y/Y Growth Statistics
High Average Low
18.38 %
 1.45 %
-38.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 152
Sector # 423
S&P 500 # 3147
Cumulative Revenue growth Comment
Baxter International Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 6.14% year on year, to $ 11,555 millions if the fiscal year would have ended in Jun 30 2026.
Baxter International Inc 's trailing twelve months Revenue growth was higher than company's average 1.45% and higher than -4.79% growth in Mar 31 2026.
But from twelve months ended Mar 31 2026 rise was beneth at 2.08 % from $11320 millions achieved in the period from Mar 31 2026 to Jun 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 1.45%.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 2.08 % increase from $11320 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 468 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3359 to 3472.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 152
Healthcare Sector # 469
Overall # 3472

Revenue TTM Y/Y Growth Statistics
High Average Low
18.38 %
1.45 %
-38.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 152
Sector # 423
S&P 500 # 3147




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BAX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Sbc Medical Group Holdings Incorporated14.36%$ 14.363 millions
Nuwellis Inc 14.14%$ 14.145 millions
West Pharmaceutical Services Inc 13.89%$ 13.892 millions
Edwards Lifesciences Corporation13.66%$ 13.657 millions
Indivior Pharmaceuticals Inc 13.58%$ 13.576 millions
Talkspace Inc 13.56%$ 13.556 millions
Atricure Inc 13.38%$ 13.376 millions
Dexcom Inc 13.11%$ 13.105 millions
Sanara Medtech Inc 13.03%$ 13.028 millions
Bausch Health Companies Inc 12.73%$ 12.727 millions
Vertex Pharmaceuticals Inc12.45%$ 12.453 millions
Genedx Holdings Corp 12.30%$ 12.304 millions
Profound Medical Corp 12.30%$ 12.302 millions
Xenetic Biosciences Inc 11.99%$ 11.986 millions
Biolife Solutions Inc 11.98%$ 11.978 millions
Repligen Corp11.93%$ 11.933 millions
Medline Inc 11.60%$ 11.603 millions
Earth Science Tech Inc 11.56%$ 11.556 millions
Immucell Corporation11.50%$ 11.501 millions
Harrow Inc 11.26%$ 11.256 millions
Rapid Micro Biosystems Inc 10.91%$ 10.906 millions
Livanova Plc10.80%$ 10.797 millions
Cerus Corporation10.52%$ 10.517 millions
Interpace Biosciences Inc 10.33%$ 10.331 millions
Warby Parker Inc 10.25%$ 10.253 millions
Neuronetics Inc 10.25%$ 10.249 millions
Elanco Animal Health Incorporated10.23%$ 10.234 millions
Quest Diagnostics Inc10.21%$ 10.214 millions
Gilead Sciences Inc 10.18%$ 10.181 millions
Lifeloc Technologies Inc 10.16%$ 10.163 millions


About Baxter International Inc Revenue Growth Rates (BAX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Baxter International Inc (CIK 10456).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-051118
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Baxter International Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.